This meeting took place in the past. For a complete list of the meetings for the upcoming/current season, see our meeting list or click on related meetings tab below to check for related meeting(s).
Web Desc
Genetic and Molecular Basis of Obesity and Body Weight Regulation
joint with Pathogenesis of Diabetes: Emerging Insights into Molecular Mechanisms
Organizer(s): Evan D. Rosen, Dawn L. Brasaemle and Bart Staels
Date: January 29 - February 03, 2012
Location: Santa Fe Community Convention Center, Santa Fe, NM, USA
Sponsored by Takeda Pharmaceutical Company Limited
Summary of Meeting:
This conference will cover the latest developments in molecular metabolism relevant to the burgeoning problem of human obesity. Topics of special relevance will include the biology of the adipocyte, novel mechanisms of lipid handling and central control of peripheral metabolism. In addition, new discoveries in epigenetics and fetal programming will be covered. Other topics will be discussed in joint sessions with the Keystone Symposia meeting on Pathogenesis of Diabetes: Emerging Insights into Molecular Mechanisms, including new developments in the genetics of metabolic disease, connections between insulin resistance and inflammation, novel mechanisms of intercellular communication between tissues in metabolism and systems approaches to obesity and diabetes. A scintillating array of world-class speakers has been selected to deliver these insights. Attendees of this meeting will be exposed to the best and the brightest thinkers in this area of critical biomedical importance.
Scholarship Deadline: September 29 2011
Discounted Abstract Deadline: September 29 2011
Abstract Deadline: November 1 2011
Discounted Registration Deadline: November 29 2011
Keystone Symposia thanks our Sponsor(s) for generously supporting this meeting:
Takeda Pharmaceutical Company Limited
We gratefully acknowledge additional support for this conference from:
AdipoGen InternationalCEDARLANEMercodia, Inc.Novartis Institutes for BioMedical ResearchTakeda California
We gratefully acknowledge additional in-kind support for this conference from those foregoing speaker expense reimbursements:

Bristol-Myers Squibb Company

Eli Lilly and Company

Metabolic Solutions Development Company, LLC.
We gratefully acknowledge the generous grant for this conference provided by:

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Grant No. 5R13DK084688-03
The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.
We appreciate the organizations that provide Keystone Symposia with additional support, such as marketing and advertising:

Click here to view more of these organizations
Special thanks to the following for their support of Keystone Symposia initiatives to increase participation at this meeting by scientists from underrepresented backgrounds:

Click here to view more of these organizations

No content found

No content found

No content found

No content found